Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Fulvia Fanelli"'
Autor:
Michele Malagola, MD, Nicola Polverelli, MD, Massimo Martino, MD, Francesca Patriarca, MD, Benedetto Bruno, MD, Luisa Giaccone, MD, Giovanni Grillo, MD, Stefania Bramanti, MD, Paolo Bernasconi, MD, Marco De Gobbi, MD, Annalisa Natale, MD, Elisabetta Terruzzi, MD, Attilio Olivieri, MD, Patrizia Chiusolo, MD, Angelo Michele Carella, MD, Marco Casini, MD, Enrico Maffini, MD, Chiara Nozzoli, MD, Patrizio Mazza, MD, Simona Bassi, Francesco Onida, MD, Adriana Vacca, MD, Sadia Falcioni, MD, Mario Luppi, MD, Anna Paola Iori, MD, Vincenzo Pavone, MD, Cristina Skert, MD, Paola Carluccio, MD, Carlo Borghero, MD, Anna Proia, MD, Carmine Selleri, MD, Vicky Rubini, MD, Nicoletta Sacchi, MD, Elena Oldani, MD, Francesca Bonifazi, MD, Fabio Ciceri, MD, Domenico Russo, MD, Simona Bernardi, Mirko Farina, Maria Fiore, Maria Teresa Lupo Stanghellini, Renato Fanin, Danilo Giuseppe Faraci, Luca Castagna, Anna Amelia Colombo, Paolo Nicoli, Stella Santarone, Ilaria Scortechini, Elisabetta Metafuni, Emanuela Merla, Irene Cavattoni, Ilaria Cutini, Annamaria Mazzone, Giorgia Saporiti, Filippo Antonio Canale, Eugenia Piras, Piero Galieni, Giulia Debbia, Ursula La Rocca, Anna Mele, Francesca Carobolante, Francesca Elice, Fulvia Fanelli
Publikováno v:
Transplantation Direct, Vol 9, Iss 3, p e1451 (2023)
Background. The conditioning regimens with different alkylators at different doses can influence the outcome of allogeneic stem cell transplantation (SCT), but conclusive data are missing. Methods. With the aim to analyze real-life allogeneic SCTs pe
Externí odkaz:
https://doaj.org/article/f52ad82b2231458eb6e334ecb921fb0f
Autor:
Fulvia Fanelli, Stefan Hohaus, Maria Cantonetti, Giuseppe Cimino, Elsa Pennese, Roberta Battistini, Eugenio Galli, Raffaella Cerretti, Anna Proia, Federica Fatone, Ida Provenzano, Elisabetta Abruzzese, Erica Finolezzi, Alessandro Pulsoni, Luigi Rigacci
Publikováno v:
Chemotherapy.
Background: Allogeneic transplant is an effective salvage therapy in patients with Hodgkin lymphoma (HL) relapsed or refractory to previous treatments. In recent years, immunotherapies (conjugated antibody and checkpoint inhibitors) showed interestin
Autor:
Fulvia Fanelli, A. Di Rocco, Elena Papa, Luigi Petrucci, Gabriella Tomei, Maria Cantonetti, Francesca Palombi, Agostino Tafuri, Cristiano Tesei, Livio Pupo, Alessandro Andriani, Roberta Battistini, S Hoaus, S Mariani, Elena Maiolo, Sabrina Pelliccia, Maria Paola Bianchi
Publikováno v:
Hematological Oncology. 39
Autor:
Edoardo La Sala, Massimo Breccia, Davide Giusti, Andrea Patriarca, Claudio Cartoni, Francesca Fazio, Elisabetta Lugli, Francesco Cottone, Elisabetta Colaci, Giovanni Caocci, Esmeralda Conte, Marco Vignetti, Claudio Fozza, Caterina Patti, Giusy Antolino, Ombretta Annibali, Paolo de Fabritiis, Nicolina Rita Ardu, Luigi Rigacci, Leonardo Potenza, Valeria Pioli, Salvatrice Mancuso, Sergio Siragusa, Michelina Santopietro, Isabella Capodanno, Mario Luppi, Massimo Pini, Paola Fazi, Maria Paola Bianchi, Agostino Tafuri, Ida Carmosino, Maria Teresa Petrucci, Pasquale Niscola, Marco Santoro, Alice Di Rocco, Fulvia Fanelli, Fabio Efficace
Background There is now great interest in using digital health tools to monitor patients' health status in real-world practice. Such tools often include electronic-patient-reported outcome (ePRO) systems in which symptoms questions are included into
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::011bab372cbb956c26b0cc0a6c0ccda8
http://hdl.handle.net/11573/1616786
http://hdl.handle.net/11573/1616786
Autor:
Piero Galieni, Mario Luppi, Giovanni Grillo, Paola Carluccio, Ursula La Rocca, Paolo Nicoli, Luisa Giaccone, Chiara Nozzoli, Simona Bassi, Patrizio Mazza, Attilio Olivieri, Renato Fanin, Filippo Antonio Canale, Eugenia Piras, Benedetto Bruno, Sonia Mammoliti, Anna Proia, Stella Santarone, Massimo Martino, Adriana Vacca, Fabio Ciceri, Patrizia Chiusolo, Giulia Debbia, Ilaria Cutini, Anna Colombo, Marco Casini, Ilaria Scortechini, Carmine Selleri, Carlo Borghero, Cristina Skert, Francesca Elice, Maria Teresa Lupo Stanghellini, Mario Arpinati, Domenico Russo, Vicky Rubini, Anna Paola Iori, Emanuela Merla, Elena Oldani, Giorgia Saporiti, Anna Mele, Francesca Patriarca, Fulvia Fanelli, Nicola Polverelli, Francesca Bonifazi, Sadia Falcioni, Vincenzo Pavone, Francesca Carobolante, Francesco Onida, Luca Castagna, Elisabetta Metafuni, Danilo Giuseppe Faraci, Stefania Bramanti, Elisabetta Terruzzi, Paolo Bernasconi, Annamaria Mazzone, Annalisa Natale, Irene Cavattoni, Marco De Gobbi, Michele Malagola, Nicoletta Sacchi, Angelo Michele Carella
Publikováno v:
Blood. 138:1786-1786
The upper age-limit for patients with hematological malignancies eligible for allo-SCT progressed to 70-75 years. As a consequence, an increase of older patients submitted to allo-SCT has been observed worldwide and in Italy as well. This registry-ba
Autor:
Fulvia Fanelli, Serena Ruggieri, Luca Prosperini, Letizia Castelli, Laura De Giglio, Nikolaos Petsas
Publikováno v:
Multiple Sclerosis (Houndmills, Basingstoke, England)
Objective: To investigate the disease-altered structure–function relationship underlying the cognitive–postural interference (CPI) phenomenon in multiple sclerosis (MS). Methods: We measured postural sway of 96 patients and 48 sex-/age-matched he
Autor:
Fulvia Fanelli, Raffaella Cerqua, Paola Cavalla, Valentina Tomassini, Carlo Pozzilli, Luca Prosperini
Publikováno v:
Multiple Sclerosis (Houndmills, Basingstoke, England)
Background: Effective therapeutic strategies to preserve function and delay progression in multiple sclerosis (MS) require early recognition of individual disease trajectories. Objectives: To determine the profiles of disability evolution, identify t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe02adcdea3741d1e9c5fa91ddec37a6
https://orca.cardiff.ac.uk/id/eprint/113902/7/1352458518790397.pdf
https://orca.cardiff.ac.uk/id/eprint/113902/7/1352458518790397.pdf
Autor:
Isabella Righini, Fulvia Fanelli, Antonio Bertolotto, Mauro Zaffaroni, Damiano Baroncini, Gianfranco Costantino, Cinzia Scandellari, Marta Simone, Maria Pia Amato, Giulia Mallucci, Giancarlo Comi, Paolo Bellantonio, Marco Capobianco, Pietro Iaffaldano, Paolo Gallo, Elio Scarpini, Monica Margoni, Silvia Miante, Lorena Lorefice, Angelo Ghezzi, N. Milani, Giuseppe Fenu, Emanuele D'Amico, Roberto Bergamaschi, Francesco Patti, Lucia Moiola
Publikováno v:
Multiple sclerosis (Houndmills, Basingstoke, England). 25(3)
Background: Few data are available on very long-term follow-up of pediatric multiple sclerosis (MS) patients treated with disease modifying treatments (DMTs). Objectives: To present a long-term follow-up of a cohort of Pediatric-MS patients starting
Publikováno v:
Journal of the Neurological Sciences. 364:145-147
In this study we assessed the proportion of patients with relapsing multiple sclerosis (R-MS) who had No Evidence of Disease Activity (NEDA-3), defined as absence of relapses, absence of confirmed disability worsening, and absence of radiological act
Autor:
Massimiliano Di Filippo, Carlo Pozzilli, Fulvia Fanelli, Ilenia Riccucci, Paolo Calabresi, Luca Prosperini, Lorenzo Gaetani, Paola Sarchielli, Paolo Eusebi
Introduction Multiple sclerosis (MS) usually presents at onset with a clinically isolated syndrome (CIS). According to 2010 McDonald criteria, a diagnosis of MS can be made if CIS patients satisfy clinical/MRI criteria of both dissemination in time (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a0ba1b94343269a346b915cae56f299f
http://hdl.handle.net/11391/1425196
http://hdl.handle.net/11391/1425196